Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer

Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

Библиографические подробности
Главный автор:	Rahman, Tasnim
Другие авторы:	Azam, Faruque
Формат:	Диссертация
Язык:	English
Опубликовано:	Brac University 2024
Предметы:	Efficacy endpoint Clinical trial Treatment size Lung cancer Lung > Cancer > Treatment
Online-ссылка:	http://hdl.handle.net/10361/22174

Схожие документы

Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
по: Paul, Pulock
Опубликовано: (2024)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
по: Flora, Sanzida Alam
Опубликовано: (2024)

Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer
по: Hoque, Ismoth Ara
Опубликовано: (2024)

Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
по: Karim, Samia Binte
Опубликовано: (2024)

Potential of liposomes for the treatment of lung cancer- a review
по: Mim, Shanzida
Опубликовано: (2023)

A review on targeted therapies for lung cancer
по: Ashraf, Anushey
Опубликовано: (2023)

A review on recent advances in drugs for lung cancer treatment
по: Noor, Fouzia
Опубликовано: (2024)

Bioinformatics analyses of key regulators of NF-κB pathway in relation with small cell lung carcinoma
по: Zangmo, Thinley
Опубликовано: (2024)

Molecules associated with the development of lung cancer
по: Rahman, Adree, и др.
Опубликовано: (2023)

Protein biomarkers for Lung Cancer: a bioinformatic approach
по: Jeba, Joynob
Опубликовано: (2017)

Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
по: Tania, Umme
Опубликовано: (2023)

Pooled analysis of progression-free survival and overall survival in phase II clinical trials of breast cancer
по: Shobnam, Sohana
Опубликовано: (2024)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
по: Razna, Amrin Islam
Опубликовано: (2019)

Immunotherapy in the Management of Lung Cancer
по: Tasnim, Humayra
Опубликовано: (2022)

A cross-sectional study on risk factors, symptoms, treatment and management strategies of lung cancer in a tertiary care cancer hospital of Bangladesh
по: Pial, Sazia Afrin
Опубликовано: (2018)

Computational insights into molecular docking strategies for non-small cell lung cancer drug discovery
по: Das, Reshita
Опубликовано: (2024)

An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
по: Bristy, Israt Zerin
Опубликовано: (2021)

A case study of lung cancer patients in term of various risk factors in context of Bangladesh
по: Shabnam, Musharrat
Опубликовано: (2018)

Current practice and approaches of immunotherapy in Cancer treatment
по: Khondokar, Faiza
Опубликовано: (2022)

Biosimilar in lymphoma treatment
по: Tanisha, Mehrin Haque
Опубликовано: (2021)

Lung cancer detection and classification using machine learning
по: Arefin, Mahbubul, и др.
Опубликовано: (2023)

Recent advancement on breast cancer detection and treatment
по: Rahman, Sanjida
Опубликовано: (2023)

Targeting BRAFV600E in the treatment of CRC
по: Roja, Mashwiyat Samrin
Опубликовано: (2024)

RIPK pathway, as a potential target, for cancer treatment - a review
по: Jahan, Nusrat
Опубликовано: (2024)

Score based risk assessment of lung cancer and its evaluation for Bangladeshi people
по: Mukti, Roushney Fatima, и др.
Опубликовано: (2016)

Lung cancer immunosuppression and therapeutic targeting of myeloid- derived suppressor cells
по: Nandy, Aditi
Опубликовано: (2022)

Potential phytochemicals and dietary components for the prevention and treatment of skin cancer: A review
по: Muntaha, Habibatul
Опубликовано: (2023)

Palliative care services in cancer treatment: a study of the current scenario in Dhaka
по: Rahman, Qazi Ashrafur
Опубликовано: (2018)

Evaluation of genetics of cancer predisposition in patients and efficacy of various chemotherapeutic drugs in Bangladesh
по: Hossain, Safa Binte
Опубликовано: (2019)

ক্যান্সার : মৃত্যু অবধারিত নয় /
по: করীম, আবুল বাশার মোহাম্মদ ফজলুল

Dendritic cell vaccine for the treatment of cancer
по: Haque, Tanzila
Опубликовано: (2023)

Prevalence and application of an evolving genome editing tool “CRISPR/Cas System” in cancer research and treatment
по: Shaikat, Mahdi Mubin
Опубликовано: (2023)

A comprehensive review on drug repurposing in cancer treatment
по: Sarkar, Onusree
Опубликовано: (2024)

Stem cells as therapeutic carrier in cancer treatment
по: Anika, Mysha Yeasmin
Опубликовано: (2022)

A review on non-polyphenolic and terpenoid phytoconstituents with antioxidant and cytotoxic potential
по: Ahmed, Kazi Zeba
Опубликовано: (2021)

Genetic innovations for breast cancer treatment : a review of gene therapy strategies and future implications
по: Hasan, Sakib
Опубликовано: (2024)

A review on nanoparticles based drug delivery in cancer treatment: advantages & challenges
по: Nahar, Kamrun
Опубликовано: (2023)

Natural products and their combinatory effects in breast cancer treatment
по: Siddique, Md. Ayman
Опубликовано: (2021)

Targeted therapeutic options in the treatment of Breast Cancer
по: Alam, Kazi Tasnuva
Опубликовано: (2022)

A review on artemisinin based combination therapy for the treatment of Malaria
по: Chowdhury, Amina Ferdous
Опубликовано: (2020)